Cold Cough Sore Throat Remedies Market

Cold, Cough and Sore Throat Remedies Market: Oral Syrups Segment Will Remain the Most Attractive and Dominant Dosage Type Segment Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016 - 2026

The oral syrups segment is expected to dominate the global cold, cough and sore throat remedies market in the coming decade

Oral syrups segment is expected to expand at 2.9% CAGR over the estimated period and be valued more than US$ 10 Bn by the end of 2026. The segment is expected to create absolute $ opportunity of a little more than US$ 300 Mn in 2017 over 2016. The segment is the most acceptable dosage form for cough, cold, and sore throat medicines due to ease of administration and pleasant taste. The oral syrups segment dominated the global cold, cough and sore throat remedies market in terms of revenue in 2016 and the trend is projected to continue throughout the forecast period. Oral syrups segment is the most attractive segment, with attractiveness index of 1.5 over the forecast period.

Pleasant taste and easy intake of oral syrups are the key factors boosting segmental growth during the forecast period

The majority of paediatric and geriatric patients prefer liquid as a delivery method over solid dosage forms, which is attributed to high proportion of oral syrups in the global cold, cough and sore throat remedies market. There is large scale adoption of oral syrups by pharmacy chains, especially in European countries, which is expected to fuel the sales of oral syrups in the global market. Most of the oral syrups are OTC (Over-the-Counter) drugs which do not need a doctor’s prescription. Consumers are conditioned to treat cold, cough and sore throat with OTC drugs than to seek healthcare professionals and this propels the growth of the oral syrups segment across the globe. Continuous launch of new and improved drug types and increasing investment in research and development by manufacturers in oral syrups would lead to the growth of the oral syrups segment in the global cold, cough and sore throat remedies market. An intake of oral syrups is suitable for all patients irrespective of their age. Particularly, oral syrups are prescribed mostly for children and elderly patients and this factor is creating a positive impact on the oral syrups segment.

Emerging markets such as Brazil, Russia, India and China represent the larger market for OTCs and generics. Pharmaceuticals industry in these countries is dominated by the private sector, where pharma companies can reap larger revenue from the strong sales of oral syrups.

cold, cough and sore throat remedies market

The oral syrups segment is projected to grow in North America during 2016-2026

Oral syrups segment dominated the North America cold, cough and sore throat remedies market by doses type segment in terms of revenue in 2016, and the trend is projected to grow throughout the forecast period. Oral syrups segment is the most attractive segment in the North America cold, cough and sore throat remedies market, with attractiveness index of 1.5 over the forecast period. Revenue from the oral syrups segment is anticipated to increase at a CAGR of 1.9% over 2016–2026, to reach more than US$ 3,000 Mn by 2026. OTC cough syrups for children are receiving exceptional attention in the U.S. by regulators, physicians and parents due to safety concerns. In the last 3 years, FDA has withdrawn more than 200 cough syrups containing hydrocodone from the market.

In Latin America, revenue from the oral syrups segment is anticipated to increase at a CAGR of 3.6% over 2016–2026, to reach more than US$ 500 Mn by 2026. The segment is expected to record attractiveness index of 1.7 over the forecast period in Western Europe. Revenue from the oral syrups segment is anticipated to increase at a CAGR of 4.1% over 2016–2026, to reach a market value of a little more than US$ 5,000 Mn by 2026 in the APEJ cold, cough and sore throat remedies market.  

Manufacturers operating in the global cold, cough and sore throat remedies market are likely to target emerging economies through mergers with established local players to increase their customer base. While considering the overall market approach the analysts of Future Market Insights have observed that key players are focussing on the need to efficiently meet requirements of various dosage types, by ensuring best combination products to effectively treat cold, cough and sore throat, and Rx to OTC switch so that products can be easily available to customers. In a new report titled “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment 2016–2026,” we have observed that strengthening of supply chain particularly in regions such as Asia Pacific excluding Japan and the Middle East and Africa are key focus areas for players in this market. According to our research, North America represents the most lucrative market, followed by Western Europe and APEJ. Presently, APEJ, MEA, Eastern Europe and Latin America regions are target markets for major players in the cold, cough and sore throat remedies market. Moreover, ease of regulations, conducive business environment and presence of large patient pools are promising factors for investors to invest in the aforementioned regions.

The key segment in the global cold, cough and sore throat remedies market is drug type segment, which is likely to witness a boost in revenue share over the forecast period owing to the high availability of single-entity and combination products. Engaging in acquisitions and mergers is a key strategy adopted by manufacturers to increase consumer base in different geographies. In short, the primary objective of the report is to offer updates and information related to market opportunities in the cold, cough and sore throat remedies market.

Report Description

Macro-economic indicators such as healthcare industry outlook, healthcare spending, Gross Domestic Products, treatment rate and epidemiology of disease have been considered to arrive at the indicated market numbers. Bottom-up approach has been used to assess market numbers while top-down approach has been used to counter-validate the reached market numbers. Yearly change in inflation rate has not been considered while forecasting market numbers. Historical trend has been analysed to track data.

The global cold, cough and sore throat remedies market report begins by defining cold, cough and sore throat disorders, symptoms associated with cold and cough, difference between cold and flu and products related to cold, cough and sore throat remedies and the relevance and impact of forecast factors used to estimate the global cold, cough and sore throat remedies market. It is followed by an overview of market dynamics of the global cold, cough and sore throat remedies market, which includes Future Market Insights’ analysis of key trends, drivers, restraints and opportunities which are influencing the development of the global cold, cough and sore throat remedies market. Impact analysis of key growth drivers and restraints based on a weighted average model has been included at a regional level in the global market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the global cold, cough and sore throat remedies market. 

The report also discusses key regional trends contributing to the revenue development of cold, cough and sore throat remedies worldwide. In the final section of the report on the global cold, cough and sore throat remedies market, detailed profiles of the cold, cough and sore throat remedies developing companies are included to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global cold, cough and sore throat remedies market.

Research Methodology

To ascertain the global cold, cough and sore throat remedies market size, we have considered revenue generated by companies operating in the cold, cough and sore throat remedies market space. The forecast presented here assesses the total revenue by value across the global cold, cough and sore throat remedies market. In order to offer an accurate forecast, we have started by sizing up the current market, which forms the basis of how the global cold, cough and sore throat remedies market is projected to develop in the future. Given the characteristics of the market, we have triangulated the outcome of three different types of analysis based on the supply side, downstream industry demand, and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse the market based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the global cold, cough and sore throat remedies market. The various market segments are analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identifying various key trends in the global cold, cough and sore throat remedies market. To understand key growth segments in terms of growth and adoption for cold, cough and sore throat remedies globally, Future Market Insights has developed the ‘Market Attractiveness Index’ for the global cold, cough and sore throat remedies market. The resulting index is estimated to help providers identify real market opportunities in the global cold, cough and sore throat remedies market.

Key segments covered in this report

By Distribution Channel

By Region

By Dosage Type

By Drug Type

  • Hospital Pharmacies

  • Retail Pharmacies

  • Drug Stores

  • Supermarket/ Hypermarkets

  •  e-Commerce/ Online pharmacies

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  • MEA

  • Oral Syrup

  • Tablets/Pills

  • Lozenges

  • Nasal Drops

  • Others

  • Antihistamines

  • Expectorants

  • Bronchodilators

  • Decongestants

  • Antibiotics

  • Others